Research Report

Zero maintenance charges
Zero fees for demat account opening
Volume based brokerage

Stock recommendation: Cipla — Buy — Target price Rs 680

Publish date: August 9, 2018

Results update: In-line quarter, US execution key

Cipla’s June quarter results were broadly in line with the market estimates due to a strong showing by its India business.

The company’s litmus test in future quarters will depend on how it fares in the United States, especially because it has launched new products in that market.

For now, though, the US market hasn’t been particularly impressive as the new launches are yet to take off. Supply constraints are one of the reasons for the laggard.

Key highlights
- Cipla’s India business was 2% above our estimates at Rs 39 billion. The domestic business grew by 22% (YoY) due to last year’s GST disruption. The two-year comparison shows the business grew by 3%.
- The US revenues stood at a $100 million, which is $5 million below estimate. We believe that the US market will come into play once the new products gain a degree of recognition. We remain confident that the new launches have good potential because of the company’s healthy approval record in the US.
- The South Africa market was strong, growing at 23% (YoY). But Africa, as a whole, was disappointing, dropping 2% (YoY).
- The rest of world figures remained fairly muted at 1% growth.
- The gross margins were disappointing, falling by 240 bps. The input costs increased by 21% due to higher payments made for purchasing sourcing materials from China.
Valuation & outlook

The potential shown by the new launches make us believe that the US market will back up the India business in a few quarters. We feel that the US business will increase to 22% by FY2020 and 25% by FY2021.

Also read
Read full report Trade now Read latest articles

Don't have an account? Click here to open an account

Click here to go back

Stock Market Sectors : A | B | C | D | E | F | G | H | I | J | L | M | N | O | P | R | S | T | V | W |

About Us

Asset Classes

Derivatives Market

Investment Knowledge Bank

CUSTOMER CARE TOLL FREE

1800 209 9191 / 1860 266 9191

Mon to Fri – 8.00 AM TO 6.00 PM
Sat – 9.00 AM to 2.00 PM To dial from Mobile phone add city STD code

Existing customers can send in their grievances for Trading account to service.securities@kotak.com
& Demat account to ks.demat@kotak.com

Connect with us

No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.

KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary. Attention Investors Prevent Unauthorized Transactions in your demat / trading account --> Update your Mobile Number/ email Id with your stock broker / Depository Participant. Receive information of your transactions directly from Exchanges on your mobile / email at the end of day and alerts on your registered mobile for all debits and other important transactions in your demat account directly from NSDL/ CDSL on the same day." - Issued in the interest of investors. Circular No.: NSDL/POLICY/2014/0094, NSE/INSP/27436, BSE - 20140901-21

Kindly note that as per NSE circulars nos: NSE/INVG/36333 dated November 17, 2017, NSE/INVG/37765 dated May 15.2018 and BSE circular nos: 20171117-18 dated November 17, 2017, 20180515-39 dated May 15.2018, trading in securities in which unsolicited messages are being circulated is restricted. The list of such stocks are available on the website of NSE & BSE. In case of any queries, request you to kindly get in touch with Customer Service on 18002099191/9292

Kotak Securities Ltd. bearing licence no. CA0268 is a Corporate Agent of Kotak Mahindra Old Mutual Life Insurance Ltd. We have taken reasonable measures to protect security and confidentiality of the Customer Information.

The Stock Exchange, Mumbai is not in any manner answerable, responsible or liable to any person or persons for any acts of omission or commission, errors, mistakes and/or violation, actual or perceived, by us or our partners, agents, associates etc., of any of the Rules, Regulations, Bye-laws of the Stock Exchange, Mumbai, SEBI Act or any other laws in force from time to time.
The Stock Exchange, Mumbai is not answerable, responsible or liable for any information on this Website or for any services rendered by our employees, our servants, and us.

Filling complaints on SCORES- Easy & Quick

a. Register on SCORES portal | b. Mandatory details for filling complaints on SCORES i. Name, PAN, Address, Mobile Number, E-mail ID | c. Benefits: i. Effective Communication ii. Speedy redressal of the grievances

Registered Office: 27 BKC, C 27, G Block, Bandra Kurla Complex, Bandra (E), Mumbai 400051. Telephone No.: +22 43360000, Fax No.: +22 67132430.
Correspondence Address: Infinity IT Park, Bldg. No 21, Opp. Film City Road, A K Vaidya Marg, Malad (East), Mumbai 400097. Telephone No: 42856825.

CIN: U99999MH1994PLC134051. SEBI Registration No: INZ000200137(Member of NSE, BSE, MSE, MCX & NCDEX), AMFI ARN 0164, PMS INP000000258 and Research Analyst INH000000586.

NSDL/CDSL: IN-DP-NSDL-23-97

New To share Market?

Open Your Account Today!

Submit

Please Note

That by submitting the above mentioned details, you are authorising Kotak Securities & its sub-brokers & agents to call you and send promotional communication even though you may be registered under DNC.

Open An Account

Research Report

Stock recommendation: Cipla — Buy — Target price Rs 680

Results update: In-line quarter, US execution key

Key highlights

Valuation & outlook

Also read